Linda Grais Purchases 10,000 Shares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Stock

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Get Rating) Director Linda Grais acquired 10,000 shares of the business’s stock in a transaction on Monday, May 15th. The stock was purchased at an average cost of $2.45 per share, with a total value of $24,500.00. Following the acquisition, the director now directly owns 10,000 shares of the company’s […]

Related Keywords

Linda Grais ,Institutional Trading Of Corvus Pharmaceuticals ,Corvus Pharmaceuticals Stock Performance ,Corvus Pharmaceuticals Company Profile ,Nasdaq ,Quarter For Corvus Pharmaceuticals ,Corvus Pharmaceuticals Inc ,Corvus Pharmaceuticals ,Securities Exchange Commission ,News Ratings For Corvus Pharmaceuticals Daily ,Vanguard Group Inc ,Renaissance Technologies ,Acadian Asset Management ,Cantor Fitzgerald ,Get Rating ,Director Linda Grais ,Exchange Commission ,Sigma Advisers ,Sigma Investments ,Asset Management ,Adenosine Production Inhibitor ,Corvus Pharmaceuticals Daily ,Nasdaq Crvs ,Ccrvs ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,